Literature DB >> 19022643

Growing old with cystic fibrosis - the characteristics of long-term survivors of cystic fibrosis.

Nicholas J Simmonds1, Paul Cullinan, Margaret E Hodson.   

Abstract

BACKGROUND: The proportion of patients with cystic fibrosis (CF) who are middle-aged is increasing - and is likely to continue to do so. We surveyed a population of long-term CF survivors to assess their burden of illness and profile their disease characteristics.
METHODS: A case series (n=112) of patients from one specialist centre who had reached their 40th birthday without transplantation. Hospital records and annual review data were examined.
RESULTS: The median age of the group was 43.1 years (range 40-71.1); 57% were men. 68% were diagnosed before 16 years of age. 30% were DeltaF508/DeltaF508, 76% having at least one DeltaF508 allele. When compared with the total adult CF population, the older patients were significantly less likely to have a DeltaF508 mutation or colonisation with Stenotrophomonas maltophilia and MRSA; but more likely to have pancreatic sufficiency, colonisation with Pseudomonas aeruginosa or allergic bronchopulmonary aspergillosis. On average they required less than one hospital admission a year; lung function and body mass index were relatively well preserved. Many were married and working.
CONCLUSIONS: We describe one of the largest surveys to date of CF patients aged more than 40 years. The full spectrum of disease is represented in this population and, importantly, 30% are DeltaF508 homozygous. Provision needs to be made for the healthcare needs of this increasing population of older patients.

Entities:  

Mesh:

Year:  2008        PMID: 19022643     DOI: 10.1016/j.rmed.2008.10.011

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  16 in total

1.  Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis.

Authors:  Jerry A Nick; Cathy S Chacon; Sara J Brayshaw; Marion C Jones; Christine M Barboa; Connie G St Clair; Robert L Young; David P Nichols; Jennifer S Janssen; Gwen A Huitt; Michael D Iseman; Charles L Daley; Jennifer L Taylor-Cousar; Frank J Accurso; Milene T Saavedra; Marci K Sontag
Journal:  Am J Respir Crit Care Med       Date:  2010-05-06       Impact factor: 21.405

2.  Insurance companies' perspectives on the orphan drug pipeline.

Authors:  Robert Handfield; Josh Feldstein
Journal:  Am Health Drug Benefits       Date:  2013-11

Review 3.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 4.  Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: progress to date.

Authors:  Frédéric Becq
Journal:  Drugs       Date:  2010-02-12       Impact factor: 9.546

Review 5.  Interventions for preventing and managing advanced liver disease in cystic fibrosis.

Authors:  Senthil K Palaniappan; Nan Nitra Than; Aung Win Thein; Soe Moe; Indra van Mourik
Journal:  Cochrane Database Syst Rev       Date:  2017-08-29

6.  Management issues for adolescents with cystic fibrosis.

Authors:  Adelaide Lindsay Withers
Journal:  Pulm Med       Date:  2012-09-06

7.  Interventions for promoting participation in shared decision-making for children and adolescents with cystic fibrosis.

Authors:  Helen Malone; Susan Biggar; Sheila Javadpour; Zai Edworthy; Greg Sheaf; Imelda Coyne
Journal:  Cochrane Database Syst Rev       Date:  2019-05-23

8.  Nutritional status of adolescents with cystic fibrosis treated at a reference center in the southeast region of Brazil.

Authors:  Ieda Regina Lopes Del Ciampo; Luiz Antonio Del Ciampo; Regina Sawamura; Laiane Renolfi de Oliveira; Maria Inez Machado Fernandes
Journal:  Ital J Pediatr       Date:  2015-07-30       Impact factor: 2.638

9.  Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate "normative adherence".

Authors:  Zhe Hui Hoo; Rachael Curley; Michael J Campbell; Stephen J Walters; Daniel Hind; Martin J Wildman
Journal:  Patient Prefer Adherence       Date:  2016-05-23       Impact factor: 2.711

10.  Evaluating outpatient transition clinics: a mixed-methods study protocol.

Authors:  Jane N T Sattoe; Mariëlle A C Peeters; Sander R Hilberink; Erwin Ista; AnneLoes van Staa
Journal:  BMJ Open       Date:  2016-08-26       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.